IL166080A0 - Sustained-release tablet composition comprising a dopamine receptor agonist - Google Patents

Sustained-release tablet composition comprising a dopamine receptor agonist

Info

Publication number
IL166080A0
IL166080A0 IL16608003A IL16608003A IL166080A0 IL 166080 A0 IL166080 A0 IL 166080A0 IL 16608003 A IL16608003 A IL 16608003A IL 16608003 A IL16608003 A IL 16608003A IL 166080 A0 IL166080 A0 IL 166080A0
Authority
IL
Israel
Prior art keywords
sustained
receptor agonist
release tablet
dopamine receptor
tablet composition
Prior art date
Application number
IL16608003A
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Priority claimed from PCT/US2003/023403 external-priority patent/WO2004011002A1/en
Publication of IL166080A0 publication Critical patent/IL166080A0/en

Links

IL16608003A 2002-07-25 2003-07-25 Sustained-release tablet composition comprising a dopamine receptor agonist IL166080A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39844702P 2002-07-25 2002-07-25
US47932703P 2003-06-18 2003-06-18
US39842703P 2003-07-25 2003-07-25
PCT/US2003/023403 WO2004011002A1 (en) 2002-07-25 2003-07-25 Sustained-release tablet composition comprising a dopamine receptor agonist

Publications (1)

Publication Number Publication Date
IL166080A0 true IL166080A0 (en) 2006-01-15

Family

ID=37215828

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16608003A IL166080A0 (en) 2002-07-25 2003-07-25 Sustained-release tablet composition comprising a dopamine receptor agonist

Country Status (1)

Country Link
IL (1) IL166080A0 (en)

Similar Documents

Publication Publication Date Title
EP1797871A4 (en) Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
HK1069111A1 (en) Pharmaceutical composition comprising a 5ht1 receptor agonist.
HK1142322A1 (en) Diaryl ethers as opioid receptor antagonist
ZA200500432B (en) Sustained-release tablet comprising reboxetine
HK1088584A1 (en) Tablet dispenser
HK1082909A1 (en) Controlled-release drug composition
EP1482896A4 (en) Aminoalkylphosphonates and related compounds as edg receptor agonists
IL165599A0 (en) Compositions containing an alpha adrenergic receptor antagonist
EP1520856A4 (en) Androgen receptor agonist
SG131946A1 (en) Ccr3 receptor antagonists
PL349838A1 (en) Dopamine d1 receptor agonist compounds
ZA200500438B (en) Sustained-release tablet composition a dopamine receptor antagonist
GB0203412D0 (en) 5-HT 2B receptor antagonists
IL166080A0 (en) Sustained-release tablet composition comprising a dopamine receptor agonist
AU2003302405A8 (en) T-cell receptors
GB0201849D0 (en) A�- adenosine receptor agonists
GB0201919D0 (en) A�-Adenosine receptor agonists
GB0215389D0 (en) Receptor
AU2003281253A8 (en) Novel delta opioid receptor ligands
GB0130576D0 (en) Dopamine D1 receptor agonist pro-drug compounds & derivatives
GB0218183D0 (en) A novel g protein-coupled receptor gave2
AU2003240730A1 (en) Morpholinylmethylureas ccr-3 receptor antagonist
IL147613A0 (en) Dispenser for tablets
GB0203413D0 (en) 5-HT 2B receptor antagonists
PL354856A1 (en) Tablet base